Literature DB >> 30673870

Combining immunotherapy and natural immune stimulants: mechanisms and clinical implications.

Khara Lucius1, Jacob Hill2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30673870      PMCID： PMC6650376          DOI： 10.1007/s00432-018-02830-x

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


× No keyword cloud information.
  25 in total

1.  PD-1 blockade augments Th1 and Th17 and suppresses Th2 responses in peripheral blood from patients with prostate and advanced melanoma cancer.

Authors:  John Dulos; Gregory J Carven; Susan J van Boxtel; Sabine Evers; Lilian J A Driessen-Engels; Willemijn Hobo; Monika A Gorecka; Anton F J de Haan; Peter Mulders; Cornelis J A Punt; Joannes F M Jacobs; Jack A Schalken; Egbert Oosterwijk; Hans van Eenennaam; Annemieke M Boots
Journal:  J Immunother       Date:  2012 Feb-Mar       Impact factor: 4.456

2.  Th17 cell plays a role in the pathogenesis of Hashimoto's thyroiditis in patients.

Authors:  Dapeng Li; Wenqian Cai; Runxia Gu; Yi Zhang; Huafeng Zhang; Ke Tang; Pingwei Xu; Foad Katirai; Wei Shi; Longqiang Wang; Tao Huang; Bo Huang
Journal:  Clin Immunol       Date:  2013-10-11       Impact factor: 3.969

3.  Early B cell changes predict autoimmunity following combination immune checkpoint blockade.

Authors:  Rituparna Das; Noffar Bar; Michelle Ferreira; Aaron M Newman; Lin Zhang; Jithendra Kini Bailur; Antonella Bacchiocchi; Harriet Kluger; Wei Wei; Ruth Halaban; Mario Sznol; Madhav V Dhodapkar; Kavita M Dhodapkar
Journal:  J Clin Invest       Date:  2018-01-08       Impact factor: 14.808

4.  Melatonin as potential inducer of Th17 cell differentiation.

Authors:  Elena M Kuklina
Journal:  Med Hypotheses       Date:  2014-07-18       Impact factor: 1.538

5.  Constant darkness enhances autoimmunity to type II collagen and exaggerates development of collagen-induced arthritis in DBA/1 mice.

Authors:  I Hansson; R Holmdahl; R Mattsson
Journal:  J Neuroimmunol       Date:  1990-04       Impact factor: 3.478

Review 6.  The role of tumour necrosis factor in the pathogenesis of immune-mediated diseases.

Authors:  C Blandizzi; P Gionchetti; A Armuzzi; R Caporali; S Chimenti; R Cimaz; L Cimino; G Lapadula; P Lionetti; A Marchesoni; A Marcellusi; F S Mennini; C Salvarani; G Girolomoni
Journal:  Int J Immunopathol Pharmacol       Date:  2014 Jan-Mar       Impact factor: 3.219

7.  Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis.

Authors:  Verena Brucklacher-Waldert; Klarissa Stuerner; Manuela Kolster; Julia Wolthausen; Eva Tolosa
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

8.  Astragalus polysaccharides enhance immune responses of HBV DNA vaccination via promoting the dendritic cell maturation and suppressing Treg frequency in mice.

Authors:  Xiaogang Du; Bing Zhao; Jinyao Li; Xiaohan Cao; Mingkun Diao; Haibo Feng; Xiaobing Chen; Zhiyu Chen; Xianyin Zeng
Journal:  Int Immunopharmacol       Date:  2012-09-21       Impact factor: 4.932

Review 9.  PD-1 and its ligands in tolerance and immunity.

Authors:  Mary E Keir; Manish J Butte; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

10.  Tumour necrosis factor, interferon-gamma and interleukins as predictive markers of antiprogrammed cell-death protein-1 treatment in advanced non-small cell lung cancer: a pragmatic approach in clinical practice.

Authors:  Efimia Boutsikou; Kalliopi Domvri; Georgia Hardavella; Dora Tsiouda; Konstantinos Zarogoulidis; Theodoros Kontakiotis
Journal:  Ther Adv Med Oncol       Date:  2018-04-07       Impact factor: 8.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.